loading...| Preferred Name | Erythromycin | |
| Synonyms |
|
|
| Definitions |
A broad-spectrum, macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C476 |
|
| CAS_Registry |
114-07-8 |
|
| CHEBI_ID |
CHEBI:42355 |
|
| Chemical_Formula |
C37H67NO13 |
|
| code |
C476 |
|
| Contributing_Source |
FDA |
|
| definition |
A broad-spectrum, macrolide antibiotic with antibacterial activity. Erythromycin diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved. |
|
| FDA_UNII_Code |
63937KV33D |
|
| Has_Salt_Form |
http://purl.obolibrary.org/obo/NCIT_C47988 http://purl.obolibrary.org/obo/NCIT_C47986 http://purl.obolibrary.org/obo/NCIT_C87759 |
|
| in_subset | ||
| label |
Erythromycin |
|
| Legacy Concept Name |
Erythromycin |
|
| NCI_Drug_Dictionary_ID |
39234 |
|
| NSC Number |
55929 |
|
| PDQ_Closed_Trial_Search_ID |
39234 |
|
| PDQ_Open_Trial_Search_ID |
39234 |
|
| Preferred_Name |
Erythromycin |
|
| prefixIRI |
NCIT:C476 |
|
| prefLabel |
Erythromycin |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance Antibiotic |
|
| UMLS_CUI |
C0014806 |
|
| subClassOf |